The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients

HPB

Volumn 18, Issue 2, 2016, Pages 192-199

  Postlewait, Lauren M ^a   Squires, Malcolm H ^a   Kooby, David A ^a   Weber, Sharon M ^b   Scoggins, Charles R ^c   Cardona, Kenneth ^a   Cho, Clifford S ^b   Martin, Robert C G ^c   Winslow, Emily R ^b   Maithel, Shishir K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; ERYTHROCYTE CONCENTRATE; FEMALE; HOSPITAL READMISSION; HUMAN; LIVER METASTASIS; LIVER RESECTION; LONG TERM SURVIVAL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; OPERATIVE BLOOD LOSS; PERINEURAL INVASION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME; ADVERSE EFFECTS; AGED; BLOOD LOSS, SURGICAL; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METASTASIS RESECTION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; METASTASECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; UNITED STATES;

EID: 84976412570     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1016/j.hpb.2015.08.003     Document Type: Article

References (33)

1. 1 Siegel, R., Ma, J., Zou, Z., Jemal, A., Cancer statistics, 2014. CA Cancer J Clin 64 (2014), 9–29.
2. 2 Smith, J.J., D'Angelica, M.I., Surgical management of hepatic metastases of colorectal cancer. Hematol Oncol Clin North Am 29 (2015), 61–84.
3. 3 Jarnagin, W.R., Gonen, M., Fong, Y., DeMatteo, R.P., Ben-Porat, L., Little, S., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236 (2002), 397–406 discussion 406–397.
4. 4 Fong, Y., Fortner, J., Sun, R.L., Brennan, M.F., Blumgart, L.H., Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999), 309–318 discussion 318–321.
5. 5 Choti, M.A., Sitzmann, J.V., Tiburi, M.F., Sumetchotimetha, W., Rangsin, R., Schulick, R.D., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002), 759–766.
6. 6 Cardona, K., Mastrodomenico, P., D'Amico, F., Shia, J., Gonen, M., Weiser, M.R., et al. Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. Ann Surg Oncol 20 (2013), 148–154.
7. 7 Asahara, T., Katayama, K., Itamoto, T., Yano, M., Hino, H., Okamoto, Y., et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23 (1999), 676–680.
8. 8 Kwon, A.H., Matsui, Y., Kamiyama, Y., Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 91 (2001), 771–778.
9. 9 Kneuertz, P.J., Patel, S.H., Chu, C.K., Maithel, S.K., Sarmiento, J.M., Delman, K.A., et al. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol 18 (2011), 1327–1334.
10. 10 Sun, C., Wang, Y., Yao, H.S., Hu, Z.Q., Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg 13 (2014), 102–110.
11. 11 Sutton, J.M., Kooby, D.A., Wilson, G.C., Squires, M.H. 3rd, Hanseman, D.J., Maithel, S.K., et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg 18 (2014), 1575–1587.
12. 12 Wang, T., Luo, L., Huang, H., Yu, J., Pan, C., Cai, X., et al. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg 97 (2014), 1827–1837.
13. 13 Miki, C., Hiro, J., Ojima, E., Inoue, Y., Mohri, Y., Kusunoki, M., Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol R Coll Radiol 18 (2006), 60–66.
14. 14 Burrows, L., Tartter, P., Effect of blood transfusions on colonic malignancy recurrent rate. Lancet, 2, 1982, 662.
15. 15 Foster, R.S. Jr., Costanza, M.C., Foster, J.C., Wanner, M.C., Foster, C.B., Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 55 (1985), 1195–1201.
16. 16 Tartter, P.I., The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216 (1992), 633–638.
17. 17 Houbiers, J.G., Brand, A., van de Watering, L.M., Hermans, J., Verwey, P.J., Bijnen, A.B., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 344 (1994), 573–578.
18. 18 Busch, O.R., Hop, W.C., Hoynck van Papendrecht, M.A., Marquet, R.L., Jeekel, J., Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328 (1993), 1372–1376.
19. 19 Cannon, R.M., Brown, R.E., St Hill, C.R., Dunki-Jacobs, E., Martin, R.C. 2nd, McMasters, K.M., et al. Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancer. Am Surg 79 (2013), 35–39.
20. 20 Rosen, C.B., Nagorney, D.M., Taswell, H.F., Helgeson, S.L., Ilstrup, D.M., van Heerden, J.A., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216 (1992), 493–504 discussion 504–495.
21. 21 Kooby, D.A., Stockman, J., Ben-Porat, L., Gonen, M., Jarnagin, W.R., Dematteo, R.P., et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237 (2003), 860–869 discussion 869–870.
22. 22 Schiergens, T.S., Rentsch, M., Kasparek, M.S., Frenes, K., Jauch, K.W., Thasler, W.E., Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 58 (2015), 74–82.
23. 23 Correa-Gallego, C., Gonen, M., Fischer, M., Grant, F., Kemeny, N.E., Arslan-Carlon, V., et al. Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. Ann Surg Oncol 20 (2013), 2477–2484.
24. 24 Gruttadauria, S., Saint Georges Chaumet, M., Pagano, D., Marsh, J.W., Bartoccelli, C., Cintorino, D., et al. Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. J Surg Oncol 103 (2011), 140–147.
25. 25 Konopke, R., Kersting, S., Bunk, A., Dietrich, J., Denz, A., Gastmeier, J., et al. Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection. Int J Colorectal Dis 24 (2009), 687–697.
26. 26 Stephenson, K.R., Steinberg, S.M., Hughes, K.S., Vetto, J.T., Sugarbaker, P.H., Chang, A.E., Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 208 (1988), 679–687.
27. 27 Wehry, J., Cannon, R., Scoggins, C.R., Puffer, L., McMasters, K.M., Martin, R.C., Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity. Am J Surg 209 (2015), 280–288.
28. 28 Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
29. 29 Vamvakas, E.C., Blajchman, M.A., Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21 (2007), 327–348.
30. 30 Opelz, G., Terasaki, P.I., Dominant effect of transfusions on kidney graft survival. Transplantation 29 (1980), 153–158.
31. 31 Ghio, M., Contini, P., Mazzei, C., Merlo, A., Filaci, G., Setti, M., et al. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?. Transfusion 41 (2001), 988–996.
32. 32 Virani, S., Michaelson, J.S., Hutter, M.M., Lancaster, R.T., Warshaw, A.L., Henderson, W.G., et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 204 (2007), 1284–1292.
33. 33 Hebert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999), 409–417.